Opinion|Videos|March 4, 2024

SPOTLIGHT Trial and 18F-rhPSMA-7.3 for Prostate Cancer

Experts in prostate cancer evaluate the data from the SPOTLIGHT trial and the use of 18F-rhPSMA-7.3 for prostate cancer.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.


Latest CME